We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted ... Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. Show more
SILVER SPRING, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, is excited to announce its participation in the...
SILVER SPRING, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a company pioneering drug-eluting biomatrix products, today provided a business...
SILVER SPRING, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its first...
SILVER SPRING, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills...
SILVER SPRING, Md., March 07, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today provided a business update and reported financial results for the fourth...
SILVER SPRING, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its fourth...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.09 | -2.69461077844 | 3.34 | 3.4875 | 2.8901 | 23497 | 3.33490283 | CS |
| 4 | 0.37 | 12.8472222222 | 2.88 | 4 | 2.72 | 24184 | 3.15836415 | CS |
| 12 | -0.31 | -8.70786516854 | 3.56 | 4 | 2.72 | 15310 | 3.18168644 | CS |
| 26 | 1.55 | 91.1764705882 | 1.7 | 4.1893 | 1.635 | 29231 | 2.78558453 | CS |
| 52 | 2.06 | 173.109243697 | 1.19 | 4.1893 | 1.1 | 175864 | 1.71848521 | CS |
| 156 | 2.06 | 173.109243697 | 1.19 | 4.1893 | 1.1 | 175864 | 1.71848521 | CS |
| 260 | 2.06 | 173.109243697 | 1.19 | 4.1893 | 1.1 | 175864 | 1.71848521 | CS |
Monksdream
11 hours ago
Monksdream
3 weeks ago
TrendTrade2016
4 months ago
Agoura Guy
4 months ago
TrendTrade2016
4 months ago
TrendTrade2016
5 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
